Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 14 $ 2,044,362 $ (5,540,875) $ (3,496,499)
Balance at the beginning (in shares) at Dec. 31, 2020 142,369      
Share-based compensation   706,006   706,006
Exchange of common shares of Marpai Health, Inc. (see Note 1) $ (14)     (14)
Exchange of common shares of Marpai Health, Inc. (in shares) (142,369)      
Issuance of common shares of Marpai, Inc. (in shares) 11,147,301      
Issuance of common shares of Marpai, Inc. (see Note 1) (1) $ 1,115 17,350,820   17,351,935
Issuance of warrants to shareholder in exchange for cash   53,333   53,333
Net loss     (5,463,588) (5,463,588)
Balance at the end at Jun. 30, 2021 $ 1,115 20,154,521 (11,004,463) 9,151,173
Balance at the end (in shares) at Jun. 30, 2021 11,147,301      
Balance at the beginning at Mar. 31, 2021 $ 14 2,325,673 (7,132,489) (4,806,802)
Balance at the beginning (in shares) at Mar. 31, 2021 142,369      
Share-based compensation   475,528   475,528
Exchange of common shares of Marpai Health, Inc. (see Note 1) $ (14)     (14)
Exchange of common shares of Marpai Health, Inc. (in shares) (142,369)      
Issuance of common shares of Marpai, Inc. (in shares) 11,147,301      
Issuance of common shares of Marpai, Inc. (see Note 1) (1) $ 1,115 17,350,820   17,351,935
Issuance of warrants to shareholder in exchange for cash   2,500   2,500
Net loss     (3,871,974) (3,871,974)
Balance at the end at Jun. 30, 2021 $ 1,115 20,154,521 (11,004,463) 9,151,173
Balance at the end (in shares) at Jun. 30, 2021 11,147,301      
Balance at the beginning at Dec. 31, 2021 $ 2,030 51,232,092 (21,525,710) $ 29,708,412
Balance at the beginning (in shares) at Dec. 31, 2021 20,299,727     20,299,727
Share-based compensation   1,493,322   $ 1,493,322
Issuance of stock upon vesting of restricted stock units $ 36     36
Issuance of stock upon vesting of restricted stock units (in shares) 360,617      
Shares issued to vendors in exchange for services $ 2 23,173   $ 23,175
Shares issued to vendors in exchange for services (in shares) 22,500     15,000
Net loss     (12,154,446) $ (12,154,446)
Balance at the end at Jun. 30, 2022 $ 2,068 52,748,587 (33,680,156) $ 19,070,499
Balance at the end (in shares) at Jun. 30, 2022 20,682,844     20,682,844
Balance at the beginning at Mar. 31, 2022 $ 2,030 51,481,080 (27,015,374) $ 24,467,736
Balance at the beginning (in shares) at Mar. 31, 2022 20,299,727      
Share-based compensation   1,244,334   1,244,334
Issuance of stock upon vesting of restricted stock units $ 36     36
Issuance of stock upon vesting of restricted stock units (in shares) 360,617      
Shares issued to vendors in exchange for services $ 2 23,173   23,175
Shares issued to vendors in exchange for services (in shares) 22,500      
Net loss     (6,664,782) (6,664,782)
Balance at the end at Jun. 30, 2022 $ 2,068 $ 52,748,587 $ (33,680,156) $ 19,070,499
Balance at the end (in shares) at Jun. 30, 2022 20,682,844     20,682,844